Once in production, which could occur as early as July, the Dome Mountain mine is expected to output 15,000 oz. of gold per ...

Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

Great Pacific Gold Corp. (TSXV: GPAC) (OTCQX: FSXLF) (FSE: V3H) ("Great Pacific Gold," "GPAC," or the "Company") is pleased ...

Mandalay Resources Corporation (“Mandalay” or the “Company”) (TSX: MND, OTCQB: MNDJF) is pleased to announce high-grade […] ...

Lucy Letby's case is to be reviewed by the Criminal Cases Review Commission (CCRC), which investigates potential miscarriages ...

The plant immune system, which differs significantly from that of humans, utilises small RNA sequences to deactivate or ...

The study met its primary endpoint with no procedure or device related serious adverse events reportedRUTHERFORD, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GCTK) (“Glucotrack” or the “Company” ...

Corporation (NASDAQ:NVNO), a medical device company with a market capitalization of $54.5 million, reported interim two-year follow-up data from its pivotal trial of the VenoValve, indicating ...

Equine surgeon Dr. Larry Bramlage says the type and length of turnout a horse gets when healing makes a crucial difference ...

Letby lost two attempts in 2024 to challenge her convictions at the Court of Appeal. The Crown Prosecution Service previously ...